Gainers
- Connect Biopharma Hldgs CNTB stock rose 44.1% to $1.6 during Friday's pre-market session. The market value of their outstanding shares is at $88.0 million.
- Ampio Pharmaceuticals AMPE stock rose 17.19% to $0.32. The market value of their outstanding shares is at $4.8 million.
- Apollomics APLM stock rose 16.08% to $5.63. The market value of their outstanding shares is at $488.6 million.
- Senseonics Holdings SENS shares moved upwards by 15.94% to $0.74. The company's market cap stands at $354.4 million.
- Akari Therapeutics AKTX shares rose 12.6% to $0.18. The market value of their outstanding shares is at $18.3 million.
- Rain Oncology RAIN stock moved upwards by 11.78% to $1.24. The company's market cap stands at $45.1 million.
Losers
- Kiora Pharmaceuticals KPRX shares fell 49.5% to $0.84 during Friday's pre-market session. The company's market cap stands at $1.7 million.
- Oncorus ONCR stock fell 33.87% to $0.12. The company's market cap stands at $3.1 million.
- Trxade Health MEDS stock decreased by 11.43% to $0.34. The market value of their outstanding shares is at $3.5 million.
- Nanoviricides NNVC shares declined by 8.05% to $1.2. The market value of their outstanding shares is at $13.9 million.
- Kymera Therapeutics KYMR shares declined by 7.83% to $27.1. The market value of their outstanding shares is at $1.4 billion.
- Eterna Therapeutics ERNA stock declined by 7.38% to $2.01. The market value of their outstanding shares is at $10.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AMPEAmpio Pharmaceuticals Inc
$0.00260-%
APLMApollomics Inc
$9.782.30%
CNTBConnect Biopharma Holdings Ltd
$1.05-%
ERNAEterna Therapeutics Inc
$0.44996.56%
KPRXKiora Pharmaceuticals Inc
$3.992.05%
KYMRKymera Therapeutics Inc
$43.707.61%
NNVCNanoviricides Inc
$1.14-4.19%
RAINRain Enhancement Technologies Holdco Inc
$4.01-3.14%
SENSSenseonics Holdings Inc
$0.90006.14%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in